RONGA, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 395
EU - Europa 236
AS - Asia 146
AF - Africa 17
Totale 794
Nazione #
US - Stati Uniti d'America 392
IT - Italia 77
SG - Singapore 59
CN - Cina 52
NL - Olanda 44
DE - Germania 28
UA - Ucraina 28
VN - Vietnam 20
FI - Finlandia 16
CI - Costa d'Avorio 13
IE - Irlanda 13
FR - Francia 9
RU - Federazione Russa 5
IN - India 4
IR - Iran 4
MA - Marocco 4
CA - Canada 3
CH - Svizzera 3
JP - Giappone 3
KR - Corea 3
BE - Belgio 2
ES - Italia 2
GB - Regno Unito 2
SE - Svezia 2
BG - Bulgaria 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TR - Turchia 1
Totale 794
Città #
Chandler 95
Singapore 49
Amsterdam 44
Jacksonville 37
Ashburn 35
Naples 30
Santa Clara 24
Dong Ket 20
Beijing 18
Millbury 14
Seattle 14
Boston 13
Princeton 13
Nanjing 10
Formia 7
Munich 7
Napoli 7
Wilmington 7
Kronberg 5
Dublin 4
Hebei 4
Lawrence 4
Norwalk 4
Buchs 3
Dallas 3
Des Moines 3
Esfahan 3
Jiaxing 3
Nanchang 3
Ottawa 3
Pune 3
Seongnam-si 3
Bologna 2
Catania 2
Darmstadt 2
Helsinki 2
Hyakuninchō 2
Moscow 2
Shenyang 2
Toulouse 2
Washington 2
Amiens 1
Baronissi 1
Beeville 1
Belgrade 1
Boardman 1
Brussels 1
Changsha 1
Changzhi 1
Chengdu 1
Falls Church 1
Ferrandina 1
Fuzhou 1
Hefei 1
Houston 1
Indiana 1
Isfahan 1
Istanbul 1
Jinan 1
Lappeenranta 1
Leuven 1
Limoges 1
Lioni 1
Madrid 1
Milan 1
Molinara 1
Montegrotto Terme 1
Nancy 1
Nanyang 1
New Delhi 1
Nocera Superiore 1
Orange 1
Pisticci 1
Puyang Chengguanzhen 1
Redwood City 1
Rende 1
Rome 1
Shanghai 1
Sofia 1
Tangshan 1
Tokyo 1
Valencia 1
Totale 551
Nome #
Synthesis and evaluation of the cytotoxic activity of novel ethyl4-[4-(4-substitutedpiperidin-1-yl)] benzyl-phenylpyrrolo[1,2-alpha] quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines 52
Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives 49
CONFORMATIONAL PREFERENCES AND BIOLOGICAL ACTIVITY OF PRION PROTEIN FRAGMENTS 47
Silver (I) n‐heterocyclic carbene complexes: A winning and broad spectrum of antimicrobial properties 46
Conformational diseases and structure-toxicity relationships:lessons from prion derived peptides 45
PRION PROTEIN MISFOLDING: CONFORMATIONAL STABILITY OF THE alpha2-HELIX 44
ROLE OF THE alpha2 HELIX IN PRION PROTEIN MISFOLDING: CONFORMATIONAL PREFERENCES OF hPrP[180-195] ANALOGUES 43
The prion protein: structural features and related toxic peptides 43
Diminished Oligomerization in the Synthesis of New Anti-Angiogenic Cyclic Peptide Using Solution Instead of Solid-Phase Cyclization 43
Effect of Salts on the Structural Behavior of hPrP 2-Helix-Derived Analogues 41
NMR structure and CD titration with metal cations of human prion α2-helix-related peptides 41
Peptide-Based Drug Delivery Systems: Future Challenges, Perspectives, and Opportunities in Nanomedicine 40
Spectroscopic analysis of synthetic PrP helix2-binding peptide constructs 38
Peptide fragment approach to prion misfolding: the alpha-2 domain 38
A thermodynamic approach to the conformational preferences of the 180–195 segment derived from the human prion protein α2-helix 36
Forward precision medicine: Micelles for active targeting driven by peptides 36
Involvement of Alpha-2 Domain in Prion Protein Conformationally-Induced Diseases 32
New Insights into the Behavior of NHC-Gold Complexes in Cancer Cells 30
Reactivity of S- or Se- containing model peptides with environmental relevant Hg ions: LC-MS/MS study 28
N-Heterocyclic Carbene (NHC) Gold(I) complexes targeting the Thioredoxin System: a mass spectrometry study 27
A CD Study of a Structure-Based Selection of N-Heterocyclic Bis-Carbene Gold(I) Complexes as Potential Ligands of the G-Quadruplex-Forming Human Telomeric hTel23 Sequence 14
Totale 813
Categoria #
all - tutte 3.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 0 2 3 1 1 13 8 10
2020/202170 0 7 3 7 9 2 9 1 8 1 3 20
2021/202273 3 0 0 7 1 1 2 2 8 1 12 36
2022/2023238 17 14 9 17 26 29 12 19 37 43 11 4
2023/2024153 8 17 22 3 10 29 0 38 2 0 14 10
2024/2025131 25 15 12 5 10 64 0 0 0 0 0 0
Totale 813